跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-193
首页
药物
AT-193
AT-193
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pellicle and novel fluoropolymer
US 7790811 B2
申请人: ASAHI GLASS CO LTD
优先权: 2003
CN
US
3 件公开
Mutant enzyme and application thereof
US 8883434 B2
申请人: NISHIO KYOICHI
优先权: 2009
CN
US
3 件公开
Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
US 2006009383 A1
申请人: THEOFAN GEORGIA
优先权: 2002
US
3 件公开
Composition and method for generating immunity to Borrelia burgdorferi
US 10695413 B2
申请人: HEALTH RESEARCH INC
优先权: 2018
US
3 件公开
Vaccine constructs and uses thereof against Staphylococcus infections
US 11324815 B2
申请人: SOCPRA SCIENCES ET GENIE SEC
优先权: 2016
CN
US
2 件公开
ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
US 2023142991 A1
申请人: NOVOZYMES AS
优先权: 2020
US
WO
2 件公开
Bacterical/permability-increasing protein(BPI) deletion analogs
US 2005130889 A1
申请人: HORWITZ ARNOLD
优先权: 2000
US
2 件公开
Photoresist polymer and photoresist composition containing the same
US 7338742 B2
申请人: HYNIX SEMICONDUCTOR INC
优先权: 2003
US
2 件公开
Use of a polypeptide to detect, prevent or treat a pathological state associated with a degenerative, neurological, autoimmune illness
EP 2081028 A1
申请人: BIOMERIEUX SA
优先权: 2000
EP
Oxime sulfonate and N-oxyimidosulfonate photoacid generators and photoresists comprising same
US 6482567 B1
申请人: SHIPLEY CO LLC
优先权: 2000
US
第 1 / 3 页
上一页
下一页
药物
反馈